| ID | PMID | SEQUENCE | NAME | LENGTH | ACTIVITY |
| 1350 | 18931881 | ETFSDLWKLL | PNC-28 | 10 | Cytotoxicity=80% µMo/ml |
| 1548 | 18656352 | RKKRRQRRR | Tat | 9 | ~10% Cytotoxicity at 100 µM |
| 1807 | None | FAKLLAKKLL | FLAK80 | 10 | LD50 =>1000 µg/ml |
| 1808 | None | FAKKLAKALL | FLAK81 | 10 | LD50 =>1000 µg/ml |
| 1809 | None | FAKKLAKKLL | FLAK82 | 10 | LD50 =31 µg/ml |
| 1810 | None | FAKLAKKLL | FLAK83M | 9 | LD50 =>1000 µg/ml |
| 1854 | None | FAKLLAKLAK | FLAK50 T1 | 10 | LD50 =615 µg/ml |
| 1859 | None | FAKLA | FLAK90 | 5 | LD50 =500 µg/ml |
| 1860 | None | FAKLF | FLAK91 | 5 | LD50 =>1000 µg/ml |
| 1861 | None | KAKLF | FLAK92 | 5 | LD50 =>1000 µg/ml |
| 1862 | None | KWKLF | FLAK93 | 5 | LD50 =600 µg/ml |
| 1872 | None | FALALKA | FLAK94 | 7 | LD50 =430 µg/ml |
| 1876 | None | FALKALKK | FLAK97 | 8 | LD50 =>1000 µg/ml |
| 1891 | None | FALALKALKKL | FLAK120 | 9 | LD50 =360 µg/ml |
| 1894 | None | FALLKL | FLAK96G | 6 | LD50 =630 µg/ml |
| 1895 | None | FALALKALKK | FLAK96F | 10 | LD50 =510 µg/ml |
| 1896 | None | FALKALKKAL | FLAK96C | 10 | LD50 =940 µg/ml |
| 1898 | None | KFKKLAKKF | Modelin-8D | 9 | LD50 =>1000 µg/ml |
| 1899 | None | KFKKLAKKW | Modelin-8E | 9 | LD50 =>1000 µg/ml |
| 1905 | None | FALALKLKKL | FLAK-120D | 10 | LD50 =550 µg/ml |
| 1906 | None | FALALKAKKL | FLAK-120C | 10 | LD50 =>1000 µg/ml |
| 1908 | None | WALAL | FLAK-120F | 5 | LD50 =260 µg/ml |
| 1911 | None | KKVVFKVKFK | KSL-1 | 10 | LD50 =340 µg/ml |
| 1912 | None | FKVKFKVKVK | KSL-7 | 10 | LD50 =315 µg/ml |
| 1959 | None | FAKLLAKKLL | FLAK80 | 10 | LD50 =740 µg/ml |
| 1960 | None | FAKKLAKALL | FLAK81 | 10 | LD50 =>1000 µg/ml |
| 1961 | None | FAKKLAKKLL | FLAK82 | 10 | LD50 =42 µg/ml |
| 1962 | None | FAKLAKKLL | FLAK83M | 9 | LD50 =>1000 µg/ml |
| 2006 | None | FAKLLAKLAK | FLAK50 T1 | 10 | LD50 =>1000 µg/ml |
| 2011 | None | FAKLA | FLAK90 | 5 | LD50 =530 µg/ml |
| 2012 | None | FAKLF | FLAK91 | 5 | LD50 =550 µg/ml |
| 2013 | None | KAKLF | FLAK92 | 5 | LD50 =>1000 µg/ml |
| 2014 | None | KWKLF | FLAK93 | 5 | LD50 =555 µg/ml |
| 2024 | None | FALALKA | FLAK94 | 7 | LD50 =560 µg/ml |
| 2028 | None | FALKALKK | FLAK97 | 8 | LD50 =>1000 µg/ml |
| 2043 | None | KWKKLAKKW | FLAK120 | 9 | LD50 =240 µg/ml |
| 2046 | None | FALLKL | FLAK96G | 6 | LD50 =>1000 µg/ml |
| 2047 | None | FALALKALKK | FLAK96F | 10 | LD50 =>1000 µg/ml |
| 2048 | None | FALKALKKAL | FLAK96C | 10 | LD50 =>1000 µg/ml |
| 2050 | None | KFKKLAKKF | Modelin-8D | 9 | LD50 =>1000 µg/ml |
| 2051 | None | KFKKLAKKW | Modelin-8E | 9 | LD50 =70 µg/ml |
| 2057 | None | FALALKLKKL | FLAK-120D | 10 | LD50 =870 µg/ml |
| 2058 | None | FALALKAKKL | FLAK-120C | 10 | LD50 =>1000 µg/ml |
| 2060 | None | WALAL | FLAK-120F | 5 | LD50 =440 µg/ml |
| 2063 | None | KKVVFKVKFK | KSL-1 | 10 | LD50 =>1000 µg/ml |
| 2064 | None | FKVKFKVKVK | KSL-7 | 10 | LD50 =530 µg/ml |
| 2111 | None | FAKLLAKKLL | FLAK80 | 10 | LD50 =740 µg/ml |
| 2112 | None | FAKKLAKALL | FLAK81 | 10 | LD50 =>1000 µg/ml |
| 2113 | None | FAKKLAKKLL | FLAK82 | 10 | LD50 =155 µg/ml |
| 2114 | None | FAKLAKKLL | FLAK83M | 9 | LD50 =>1000 µg/ml |
| 2158 | None | FAKLLAKLAK | FLAK50 T1 | 10 | LD50 =635 µg/ml |
| 2163 | None | FAKLA | FLAK90 | 5 | LD50 =330 µg/ml |
| 2164 | None | FAKLF | FLAK91 | 5 | LD50 =>1000 µg/ml |
| 2165 | None | KAKLF | FLAK92 | 5 | LD50 =>1000 µg/ml |
| 2166 | None | KWKLF | FLAK93 | 5 | LD50 =>1000 µg/ml |
| 2176 | None | FALALKA | FLAK94 | 7 | LD50 =465 µg/ml |
| 2180 | None | FALKALKK | FLAK97 | 8 | LD50 =>1000 µg/ml |
| 2195 | None | FALALKALKKL | FLAK120 | 9 | LD50 =240 µg/ml |
| 2198 | None | FALLKL | FLAK96G | 6 | LD50 =590 µg/ml |
| 2199 | None | FALALKALKK | FLAK96F | 10 | LD50 =530 µg/ml |
| 2200 | None | FALKALKKAL | FLAK96C | 10 | LD50 =>1000 µg/ml |
| 2202 | None | KFKKLAKKF | Modelin-8D | 9 | LD50 =>1000 µg/ml |
| 2203 | None | KFKKLAKKW | Modelin-8E | 9 | LD50 =>1000 µg/ml |
| 2209 | None | FALALKLKKL | FLAK-120D | 10 | LD50 =830 µg/ml |
| 2210 | None | FALALKAKKL | FLAK-120C | 10 | LD50 =>1000 µg/ml |
| 2212 | None | WALAL | FLAK-120F | 5 | LD50 =600 µg/ml |
| 2215 | None | KKVVFKVKFK | KSL-1 | 10 | LD50 =700 µg/ml |
| 2216 | None | FKVKFKVKVK | KSL-7 | 10 | LD50 =330 µg/ml |
| 2263 | None | FAKLLAKKLL | FLAK80 | 10 | LD50 =740 µg/ml |
| 2264 | None | FAKKLAKALL | FLAK81 | 10 | LD50 =>1000 µg/ml |
| 2265 | None | FAKKLAKKLL | FLAK82 | 10 | LD50 =155 µg/ml |
| 2266 | None | FAKLAKKLL | FLAK83M | 9 | LD50 =>1000 µg/ml |
| 2310 | None | FAKLLAKLAK | FLAK50 T1 | 10 | LD50 =635 µg/ml |
| 2315 | None | FAKLA | FLAK90 | 5 | LD50 =330 µg/ml |
| 2316 | None | FAKLF | FLAK91 | 5 | LD50 =>1000 µg/ml |
| 2317 | None | KAKLF | FLAK92 | 5 | LD50 =>1000 µg/ml |
| 2318 | None | KWKLF | FLAK93 | 5 | LD50 =>1000 µg/ml |
| 2328 | None | FALALKA | FLAK94 | 7 | LD50 =465 µg/ml |
| 2332 | None | FALKALKK | FLAK97 | 8 | LD50 =>1000 µg/ml |
| 2347 | None | FALALKALKKL | FLAK120 | 9 | LD50 =240 µg/ml |
| 2350 | None | FALLKL | FLAK96G | 6 | LD50 =590 µg/ml |
| 2351 | None | FALALKALKK | FLAK96F | 10 | LD50 =530 µg/ml |
| 2352 | None | FALKALKKAL | FLAK96C | 10 | LD50 =>1000 µg/ml |
| 2354 | None | KFKKLAKKF | Modelin-8D | 9 | LD50 =>1000 µg/ml |
| 2355 | None | KFKKLAKKW | Modelin-8E | 9 | LD50 =>1000 µg/ml |
| 2361 | None | FALALKLKKL | FLAK-120D | 10 | LD50 =830 µg/ml |
| 2362 | None | FALALKAKKL | FLAK-120C | 10 | LD50 =>1000 µg/ml |
| 2364 | None | WALAL | FLAK-120F | 5 | LD50 =600 µg/ml |
| 2367 | None | KKVVFKVKFK | KSL-1 | 10 | LD50 =700 µg/ml |
| 2368 | None | FKVKFKVKVK | KSL-7 | 10 | LD50 =330 µg/ml |
| 2415 | None | FAKLLAKKLL | FLAK80 | 10 | LD50 =>1000 µg/ml |
| 2416 | None | FAKKLAKALL | FLAK81 | 10 | LD50 =>1000 µg/ml |
| 2417 | None | FAKKLAKKLL | FLAK82 | 10 | LD50 =180 µg/ml |
| 2418 | None | FAKLAKKLL | FLAK83M | 9 | LD50 =>1000 µg/ml |
| 2463 | None | FAKLLAKLAK | FLAK50 T1 | 10 | LD50 =>1000 µg/ml |
| 2468 | None | FAKLA | FLAK90 | 5 | LD50 =>1000 µg/ml |
| 2469 | None | FAKLF | FLAK91 | 5 | LD50 =790 µg/ml |
| 2470 | None | KAKLF | FLAK92 | 5 | LD50 =>1000 µg/ml |
| 2471 | None | KWKLF | FLAK93 | 5 | LD50 =>1000 µg/ml |
| 2481 | None | FALALKA | FLAK94 | 7 | LD50 =>1000 µg/ml |
| 2485 | None | FALKALKK | FLAK97 | 8 | LD50 =>1000 µg/ml |
| 2500 | None | FALALKALKKL | FLAK120 | 9 | LD50 =56 µg/ml |
| 2503 | None | FALLKL | FLAK96G | 6 | LD50 =>1000 µg/ml |
| 2504 | None | FALALKALKK | FLAK96F | 10 | LD50 =640 µg/ml |
| 2505 | None | FALKALKKAL | FLAK96C | 10 | LD50 =>1000 µg/ml |
| 2507 | None | KFKKLAKKF | Modelin-8D | 9 | LD50 =>1000 µg/ml |
| 2508 | None | KFKKLAKKW | Modelin-8E | 9 | LD50 =>1000 µg/ml |
| 2514 | None | FALALKLKKL | FLAK-120D | 10 | LD50 =>1000 µg/ml |
| 2515 | None | FALALKAKKL | FLAK-120C | 10 | LD50 =>1000 µg/ml |
| 2517 | None | WALAL | FLAK-120F | 5 | LD50 =370 µg/ml |
| 2520 | None | KKVVFKVKFK | KSL-1 | 10 | LD50 =720 µg/ml |
| 2521 | None | FKVKFKVKVK | KSL-7 | 10 | LD50 =345 µg/ml |
| 2558 | None | FAKLLAKKLL | FLAK80 | 10 | LD50 =>1000 µg/ml |
| 2559 | None | FAKKLAKALL | FLAK81 | 10 | LD50 =>1000 µg/ml |
| 2560 | None | FAKKLAKKLL | FLAK82 | 10 | LD50 =81 µg/ml |
| 2561 | None | FAKLAKKLL | FLAK83M | 9 | LD50 =>1000 µg/ml |
| 2606 | None | FAKLLAKLAK | FLAK50 T1 | 10 | LD50 =>1000 µg/ml |
| 2611 | None | FAKLA | FLAK90 | 5 | LD50 =>1000 µg/ml |
| 2612 | None | FAKLF | FLAK91 | 5 | LD50 =>1000 µg/ml |
| 2613 | None | KAKLF | FLAK92 | 5 | LD50 =>1000 µg/ml |
| 2614 | None | KWKLF | FLAK93 | 5 | LD50 =>1000 µg/ml |
| 2624 | None | FALALKA | FLAK94 | 7 | Not Available |
| 2628 | None | FALKALKK | FLAK97 | 8 | LD50 =>1000 µg/ml |
| 2643 | None | FALALKALKKL | FLAK120 | 9 | LD50 =340 µg/ml |
| 2646 | None | FALLKL | FLAK96G | 6 | LD50 =>1000 µg/ml |
| 2647 | None | FALALKALKK | FLAK96F | 10 | LD50 =>1000 µg/ml |
| 2648 | None | FALKALKKAL | FLAK96C | 10 | LD50 =>1000 µg/ml |
| 2650 | None | KFKKLAKKF | Modelin-8D | 9 | LD50 =>1000 µg/ml |
| 2651 | None | KFKKLAKKW | Modelin-8E | 9 | LD50 =>1000 µg/ml |
| 2657 | None | FALALKLKKL | FLAK-120D | 10 | LD50 =>1000 µg/ml |
| 2658 | None | FALALKAKKL | FLAK-120C | 10 | LD50 =>1000 µg/ml |
| 2660 | None | WALAL | FLAK-120F | 5 | LD50 =570 µg/ml |
| 2663 | None | KKVVFKVKFK | KSL-1 | 10 | LD50 =>1000 µg/ml |
| 2664 | None | FKVKFKVKVK | KSL-7 | 10 | LD50 =530 µg/ml |
| 2701 | None | FAKLLAKKLL | FLAK80 | 10 | LD50 =830 µg/ml |
| 2702 | None | FAKKLAKALL | FLAK81 | 10 | LD50 =>1000 µg/ml |
| 2703 | None | FAKKLAKKLL | FLAK82 | 10 | Not Available |
| 2704 | None | FAKLAKKLL | FLAK83M | 9 | LD50 =>1000 µg/ml |
| 2749 | None | FAKLLAKLAK | FLAK50 T1 | 10 | LD50 =940 µg/ml |
| 2754 | None | FAKLA | FLAK90 | 5 | LD50 =700 µg/ml |
| 2755 | None | FAKLF | FLAK91 | 5 | LD50 =550 µg/ml |
| 2756 | None | KAKLF | FLAK92 | 5 | LD50 = >1000 µg/ml |
| 2757 | None | KWKLF | FLAK93 | 5 | LD50 = >1000 µg/ml |
| 2767 | None | FALALKA | FLAK94 | 7 | LD50 = >1000 µg/ml |
| 2771 | None | FALKALKK | FLAK97 | 8 | LD50 =240 µg/ml |
| 2786 | None | FALALKALKKL | FLAK120 | 9 | LD50 =400 µg/ml |
| 2789 | None | FALLKL | FLAK96G | 6 | LD50 = >1000 µg/ml |
| 2790 | None | FALALKALKK | FLAK96F | 10 | LD50 = >1000 µg/ml |
| 2791 | None | FALKALKKAL | FLAK96C | 10 | LD50 = >1000 µg/ml |
| 2793 | None | KFKKLAKKF | Modelin-8D | 9 | LD50 = >1000 µg/ml |
| 2794 | None | KFKKLAKKW | Modelin-8E | 9 | LD50 =510 µg/ml |
| 2800 | None | FALALKLKKL | FLAK-120D | 10 | LD50 = >1000 µg/ml |
| 2801 | None | FALALKAKKL | FLAK-120C | 10 | LD50 = >1000 µg/ml |
| 2803 | None | WALAL | FLAK-120F | 5 | LD50 =302 µg/ml |
| 2806 | None | KKVVFKVKFK | KSL-1 | 10 | LD50 = >1000 µg/ml |
| 2807 | None | FKVKFKVKVK | KSL-7 | 10 | LD50 =>1000 µg/ml |
| 2810 | 23000474 | RRRRRNWMWC | 9R | 10 | IC50=44 µM |
| 2811 | 23000474 | RRRRRWCMNW | 9S1R | 10 | IC50=26 µM |
| 2812 | 23000474 | RRRRRNWMWC | 9R | 10 | IC50=23 µM |
| 2813 | 23000474 | RRRRRWCMNW | 9S1R | 10 | IC50=9 µM |
| 2814 | 23000474 | RRRRRNWMWC | 9R | 10 | IC50=28 µM |
| 2815 | 23000474 | RRRRRWCMNW | 9S1R | 10 | IC50=8 µM |
| 2816 | 23000474 | RRRRRNWMWC | 9R | 10 | IC50=39 µM |
| 2817 | 23000474 | RRRRRWCMNW | 9S1R | 10 | IC50=18 µM |
| 2818 | 23000474 | RRRRRNWMWC | 9R | 10 | IC50=29 µM |
| 2819 | 23000474 | RRRRRWCMNW | 9S1R | 10 | IC50=12 µM |
| 2820 | 23000474 | RRRRRNWMWC | 9R | 10 | IC50=16 µM |
| 2821 | 23000474 | RRRRRWCMNW | 9S1R | 10 | IC50=10 µM |
| 2822 | 23000474 | RRRRRNWMWC | 9R | 10 | IC50=93 µM |
| 2823 | 23000474 | RRRRRWCMNW | 9S1R | 10 | IC50=38 µM |
| 2824 | 23000474 | RRRRRNWMWC | 9R | 10 | IC50=39 µM |
| 2825 | 23000474 | RRRRRWCMNW | 9S1R | 10 | IC50=43 µM |
| 2826 | 23000474 | RRRRRNWMWC | 9R | 10 | IC50=37 µM |
| 2827 | 23000474 | RRRRRWCMNW | 9S1R | 10 | IC50=43 µM |
| 2828 | 23000474 | RRRRRNWMWC | 9R | 10 | IC50=36 µM |
| 2829 | 23000474 | RRRRRWCMNW | 9S1R | 10 | IC50=45 µM |
| 2830 | 23000474 | RRRRRNWMWC | 9R | 10 | IC50=25 µM |
| 2831 | 23000474 | RRRRRWCMNW | 9S1R | 10 | IC50=36 µM |
| 2832 | 23000474 | RRRRRNWMWC | 9R | 10 | IC50=47 µM |
| 2833 | 23000474 | RRRRRWCMNW | 9S1R | 10 | IC50=26 µM |
| 2834 | 23000474 | RRRRRNWMWC | 9R | 10 | IC50=12 µM |
| 2835 | 23000474 | RRRRRWCMNW | 9S1R | 10 | IC50=17 µM |
| 2839 | 24246647 | GIIKKIIKKI | Short α-helical peptides | 10 | 99% Cytotoxicity at 4 µM Approx |
| 2842 | 24246647 | GIIKKIIKKI | Short α-helical peptides | 10 | 100% Cytotoxicity at 5 µM Approx |
| 3140 | 23627474 | CHHNLTHAC | PTPRJ-pep19 | 9 | 4.5 ± 0.1.4% cell growth inhibition at 160 µM in 48 hours |
| 3141 | 23627474 | CHHNLTHAC | PTPRJ-pep19 | 9 | 19 ± 2.82% cell growth inhibition at 160 µM in 72 hours |
| 3142 | 23627474 | CHHNLTHAC | PTPRJ-pep19.0 | 9 | 4 ± 1.4% cell growth inhibition at 160 µM in 72 hours |
| 3143 | 23627474 | CAHNLTHAC | PTPRJ-pep19.2 | 9 | 16.5 ± 2.12% cell growth inhibition at 160 µM in 24 hours |
| 3144 | 23627474 | CAHNLTHAC | PTPRJ-pep19.2 | 9 | 30 ± 2.82% cell growth inhibition at 160 µM in 48 hours |
| 3145 | 23627474 | CAHNLTHAC | PTPRJ-pep19.2 | 9 | 32.0 ± 4.2% cell growth inhibition at 160 µM in 72 hours |
| 3146 | 23627474 | CHANLTHAC | PTPRJ-pep19.3 | 9 | 28 ± 5.5% cell growth inhibition at 160 µM in 24 hours |
| 3147 | 23627474 | CHANLTHAC | PTPRJ-pep19.3 | 9 | 46 ± 4.2% cell growth inhibition at 160 µM in 48 hours |
| 3148 | 23627474 | CHANLTHAC | PTPRJ-pep19.3 | 9 | 51 ± 1.4% cell growth inhibition at 160 µM in 72 hours |
| 3149 | 23627474 | CHHALTHAC | PTPRJ-pep19.4 | 9 | 48.0 ± 2.82% cell growth inhibition at 160 µM in 24 hours |
| 3150 | 23627474 | CHHALTHAC | PTPRJ-pep19.4 | 9 | 62.5 ± 4.9% cell growth inhibition at 160 µM in 48 hours |
| 3151 | 23627474 | CHHALTHAC | PTPRJ-pep19.4 | 9 | 66.5 ± 2.12% cell growth inhibition at 160 µM in 72 hours |
| 3152 | 23627474 | CHHNATHAC | PTPRJ-pep19.5 | 9 | 2 ± 1.5% cell growth inhibition at 160 µM in 48 hours |
| 3153 | 23627474 | CHHNATHAC | PTPRJ-pep19.5 | 9 | 19 ± 4.2% cell growth inhibition at 160 µM in 72 hours |
| 3154 | 23627474 | CHHNLAHAC | PTPRJ-pep19.6 | 9 | 19 ± 4.2% cell growth inhibition at 160 µM in 72 hours |
| 3155 | 23627474 | CHHNLTAAC | PTPRJ-pep19.7 | 9 | 4.5 ± 2.13% cell growth inhibition at 160 µM in 48 hours |
| 3156 | 23627474 | CHHNLTAAC | PTPRJ-pep19.7 | 9 | 20 ± 1.4% cell growth inhibition at 160 µM in 72 hours |
| 3157 | 23301519 | WRWRWRWRW | Cyclic [W(RW)4 ]-Dox | 9 | 62-73% inhibition of cell proliferation at 1 µM |
| 3158 | 23301519 | WRWRWRWRW | Cyclic [W(RW)4 ]-Dox | 9 | 51-74% inhibition of cell proliferation at 1 µM |
| 3159 | 23301519 | WRWRWRWRW | Cyclic [W(RW)4 ]-Dox | 9 | 50-67% inhibition of cell proliferation at 1 µM |
| 3160 | 23301519 | WRWRWRWRW | Cyclic [W(RW)4 ]-Dox | 9 | 60-79% inhibition of cell proliferation at 1 µM |
| 3161 | 23301519 | RWRWRWRW | linear (RW)4-Dox | 8 | 46-69% antiproliferative activity at 1 µM |
| 3162 | 23301519 | RWRWRWRW | linear (RW)4-Dox | 8 | 28-34% antiproliferative activity at 1 µM |
| 3163 | 23301519 | RWRWRWRW | linear (RW)4-Dox | 8 | 21-61% antiproliferative activity at 1 µM |
| 3164 | 23301519 | RWRWRWRW | linear (RW)4-Dox | 8 | 60-74% antiproliferative activity at 1 µM |
| 3198 | 22184121 | MTLTG | BPP-II | 5 | NA |
| 3200 | 22184121 | MTLTG | BPP-II | 5 | NA |
| 3201 | 22184121 | MTLTG | BPP-II | 5 | NA |
| 3202 | 22184121 | MTLTG | BPP-II | 5 | NA |
| 3203 | 22184121 | MTLTG | BPP-II | 5 | NA |
| 3204 | 22184121 | MTLTG | BPP-II | 5 | NA |
| 3205 | 22184121 | MTLTG | BPP-II | 5 | NA |
| 3208 | 22184121 | MTLTG | BPP-II | 5 | NA |
| 3210 | 22184121 | MTLTG | BPP-II | 5 | NA |
| 3211 | 22184121 | MTLTG | BPP-II | 5 | NA |
| 3212 | 22184121 | MTLTG | BPP-II | 5 | NA |
| 3213 | 22184121 | MTLTG | BPP-II | 5 | NA |
| 3214 | 22184121 | MTLTG | BPP-II | 5 | NA |
| 3215 | 22184121 | MTLTG | BPP-II | 5 | NA |
| 3305 | 21453492 | WKKW-Dip-KKWK | LTX-302 | 9 | IC50 =75 ± 5 µM |
| 3306 | 21453492 | WKKW-Dip-KKWK | LTX-302 | 9 | IC50 =73 ± 2 µM |
| 3307 | 21453492 | WKKW-Dip-KKWK | LTX-302 | 9 | IC50 =28 ± 0 µM |
| 3308 | 21453492 | KKWWKKW-Dip-K | LTX-315 | 9 | IC50 =38 ± 3 µM |
| 3309 | 21453492 | KKWWKKW-Dip-K | LTX-315 | 9 | IC50 =31 ± 3 µM |
| 3310 | 21453492 | KKWWKKW-Dip-K | LTX-315 | 9 | IC50 =14 ± 1 µM |
| 3311 | 21453492 | OOW-Dip-OOWWO | LTX-318 | 9 | IC50 =248 ± 5 µM |
| 3312 | 21453492 | OOW-Dip-OOWWO | LTX-318 | 9 | IC50 =216 ± 36 µM |
| 3313 | 21453492 | OOW-Dip-OOWWO | LTX-318 | 9 | IC50 =78 ± 7 µM |
| 3343 | 23533710 | RYLGYL | αs1-casein f(90_95) | 6 | Inhibition at 12-15g/l |
| 3344 | 23533710 | PPPEE | Caseinphosphopeptides | 5 | Inhibition at 24-28g/l |
| 3720 | 9815815 | fA*YwKA*T | Lan-7 | 7 | IC50=17.05±6.61 µM |
| 3721 | 9815815 | fA*YwKA*T | Lan-7 | 7 | IC50= 16.93±1.84 µM |
| 3722 | 9815815 | fA*YwKA*T | Lan-7 | 7 | IC50= 33.88±1.98 µM |
| 3723 | 9815815 | fA*YwKA*T | Lan-7 | 7 | IC50= 27.69±2.17 µM |
| 3724 | 9815815 | fA*YwKA*T | Lan-7 | 7 | IC50= 29.97±1.19 µM |
| 3725 | 9815815 | fA*YwKA*T | Lan-7 | 7 | IC50= 36.81±0.40 µM |
| 3773 | 22933412 | KKWβ2,2WKK | c1 | 7 | IC50= 10±2 µMol/L |
| 3774 | 22933412 | KW β2,2WKK | c2 | 6 | IC50= 7.9±0.3 µMol/L |
| 3775 | 22933412 | KK β2,2WKK | c3 | 6 | IC50= 15±2 µMol/L |
| 3776 | 22933412 | KW β2,2KK | c4 | 5 | IC50= 12.6±0.6 µMol/L |
| 3777 | 22933412 | KKW β2,2WKK | c5 | 7 | IC50= 11±2 µMol/L |
| 3778 | 22933412 | KW β2,2WKK | c6 | 6 | IC50= 8±1 µMol/L |
| 3779 | 22933412 | KK β2,2WKK | c7 | 6 | IC50= 16±5 µMol/L |
| 3780 | 22933412 | KW β2,2KK | c8 | 5 | IC50= 20±2 µMol/L |
| 3781 | 22933412 | KKWβ2,2WKK | c1 | 7 | IC50= 22±5 µMol/L |
| 3782 | 22933412 | KW β2,2WKK | c2 | 6 | IC50= 1.71±0.6 µMol/L |
| 3783 | 22933412 | KK β2,2WKK | c3 | 6 | IC50= 92±2 µMol/L |
| 3784 | 22933412 | KW β2,2KK | c4 | 5 | IC50= 99±15 µMol/L |
| 3785 | 22933412 | KKW β2,2WKK | c5 | 7 | IC50= 23±3 µMol/L |
| 3786 | 22933412 | KW β2,2WKK | c6 | 6 | IC50= 26±2 µMol/L |
| 3787 | 22933412 | KK β2,2WKK | c7 | 6 | IC50= 157±30 µMol/L |
| 3788 | 22933412 | KW β2,2KK | c8 | 5 | IC50= 226±21 µMol/L |
| 3966 | 16722632 | YA*GFM | 17 | 5 | 1.0% inhibition at 10-6M |
| 3967 | 16722632 | YA*GFM | 17 | 5 | 10.1% inhibition at 10-5M |
| 3968 | 16722632 | YA*GFM | 17 | 5 | 16.8% inhibition at 10-4M |
| 3969 | 16722632 | YA*GFM | 17 | 5 | 36.1% inhibition at 10-3M |
| 3970 | 16722632 | YA*GFM | 17 | 5 | 4.9% inhibition at 10-6M |
| 3971 | 16722632 | YA*GFM | 17 | 5 | 10.2% inhibition at 10-5M |
| 3972 | 16722632 | YA*GFM | 17 | 5 | 13.3% inhibition at 10-4M |
| 3973 | 16722632 | YA*GFM | 17 | 5 | 28.0% inhibition at 10-3M |
| 3974 | 16722632 | YA*GFM | 17 | 5 | 0.8% inhibition at 10-6M |
| 3975 | 16722632 | YA*GFM | 17 | 5 | 1.4% inhibition at 10-5M |
| 3976 | 16722632 | YA*GFM | 17 | 5 | 2.4% inhibition at 10-4M |
| 3977 | 16722632 | YA*GFM | 17 | 5 | 18.3% inhibition at 10-3M |
| 3978 | 16722632 | YA*GFM | 17 | 5 | 3.3% inhibition at 10-6M |
| 3979 | 16722632 | YA*GFM | 17 | 5 | 11.0% inhibition at 10-5M |
| 3980 | 16722632 | YA*GFM | 17 | 5 | 7.9% inhibition at 10-4M |
| 3981 | 16722632 | YA*GFM | 17 | 5 | 23.7% inhibition at 10-3M |
| 3982 | 16722632 | YA*GFM | 17 | 5 | 12.2% inhibition at 10-6M |
| 3983 | 16722632 | YA*GFM | 17 | 5 | 15.5% inhibition at 10-5M |
| 3984 | 16722632 | YA*GFM | 17 | 5 | 24.7% inhibition at 10-4M |
| 3985 | 16722632 | YA*GFM | 17 | 5 | 29.0% inhibition at 10-3M |
| 3986 | 16722632 | YA*GFM | 17 | 5 | 3.0% inhibition at 10-6M |
| 3987 | 16722632 | YA*GFM | 17 | 5 | 8.4% inhibition at 10-5M |
| 3988 | 16722632 | YA*GFM | 17 | 5 | 18.5% inhibition at 10-4M |
| 3989 | 16722632 | YA*GFM | 17 | 5 | 10.6% inhibition at 10-3M |
| 3990 | 16722632 | YA*GFM | 17 | 5 | 22.8% inhibition at 10-3M |
| 3991 | 16722632 | YA*GFM | 18 | 5 | 13.7% inhibition at 10-6M |
| 3992 | 16722632 | YA*GFM | 18 | 5 | 25.8% inhibition at 10-5M |
| 3993 | 16722632 | YA*GFM | 18 | 5 | 34.7% inhibition at 10-4M |
| 3994 | 16722632 | YA*GFM | 18 | 5 | 44.5% inhibition at 10-3M |
| 3995 | 16722632 | YA*GFM | 18 | 5 | 8.5% inhibition at 10-6M |
| 3996 | 16722632 | YA*GFM | 18 | 5 | 9.5% inhibition at 10-5M |
| 3997 | 16722632 | YA*GFM | 18 | 5 | 15.4% inhibition at 10-4M |
| 3998 | 16722632 | YA*GFM | 18 | 5 | 24.1% inhibition at 10-3M |
| 3999 | 16722632 | YA*GFM | 18 | 5 | 2.4% inhibition at 10-6M |
| 4000 | 16722632 | YA*GFM | 18 | 5 | 4.5% inhibition at 10-5M |
| 4001 | 16722632 | YA*GFM | 18 | 5 | 11.4% inhibition at 10-4M |
| 4002 | 16722632 | YA*GFM | 18 | 5 | 23.2% inhibition at 10-3M |
| 4003 | 16722632 | YA*GFM | 18 | 5 | 16.2% inhibition at 10-6M |
| 4004 | 16722632 | YA*GFM | 18 | 5 | 6.6% inhibition at 10-5M |
| 4005 | 16722632 | YA*GFM | 18 | 5 | 5.1% inhibition at 10-4M |
| 4006 | 16722632 | YA*GFM | 18 | 5 | 14.5% inhibition at 10-3M |
| 4007 | 16722632 | YA*GFM | 18 | 5 | 26.4% inhibition at 10-6M |
| 4008 | 16722632 | YA*GFM | 18 | 5 | 13.1% inhibition at 10-5M |
| 4009 | 16722632 | YA*GFM | 18 | 5 | 14.6% inhibition at 10-4M |
| 4010 | 16722632 | YA*GFM | 18 | 5 | 38.4% inhibition at 10-3M |
| 4011 | 16722632 | YA*GFM | 18 | 5 | 17.7% inhibition at 10-6M |
| 4012 | 16722632 | YA*GFM | 18 | 5 | 10.9% inhibition at 10-5M |
| 4013 | 16722632 | YA*GFM | 18 | 5 | 12.1% inhibition at 10-4M |
| 4014 | 16722632 | YA*GFM | 18 | 5 | 8.1% inhibition at 10-3M |
| 4015 | 16722632 | YA*GFM | 18 | 5 | 9.6% inhibition at 10-4M |
| 4016 | 16722632 | YA*GFM | 18 | 5 | 29.9% inhibition at 10-3M |
| 4017 | 16722632 | YGGFMA* | 23 | 6 | 3.9% inhibition at 10-5M |
| 4018 | 16722632 | YGGFMA* | 23 | 6 | 45% inhibition at 10-3M |
| 4019 | 16722632 | YGGFMA* | 23 | 6 | 9.3% inhibition at 10-3M |
| 4020 | 16722632 | YGGFMA* | 23 | 6 | 4.1% inhibition at 10-6M |
| 4021 | 16722632 | YGGFMA* | 23 | 6 | 70.7% inhibition at 10-5M |
| 4022 | 16722632 | YGGFMA* | 23 | 6 | 34.4% inhibition at 10-3M |
| 4023 | 16722632 | YGGFMA* | 23 | 6 | 9.2% inhibition at 10-3M |
| 4024 | 16722632 | YGGFMA* | 23 | 6 | 11.08% inhibition at 10-5M |
| 4025 | 16722632 | YGGFMA* | 23 | 6 | 47.0% inhibition at 10-3M |
| 4026 | 16722632 | YGGFMA* | 23 | 6 | 2.2% inhibition at 10-6M |
| 4027 | 16722632 | YGGFMA* | 23 | 6 | 7.1% inhibition at 10-5M |
| 4028 | 16722632 | YGGFMA* | 23 | 6 | 6.9% inhibition at 10-4M |
| 4029 | 16722632 | YGGFMA* | 23 | 6 | 25.9% inhibition at 10-3M |
| 4174 | 14991605 | KIFGSLAFL | p369-CTL-A2xneu | 9 | 0.1% Inhibition at 10-10 M |
| 4175 | 14991605 | KIFGSLAFL | p369-CTL-A2xneu | 9 | 1% Inhibition at 10-9 M |
| 4176 | 14991605 | KIFGSLAFL | p369-CTL-A2xneu | 9 | 5% Inhibition at 10-8 M |
| 4177 | 14991605 | KIFGSLAFL | p369-CTL-A2xneu | 9 | 10% Inhibition at 10-7 M |
| 4178 | 14991605 | KIFGSLAFL | p369-CTL-A2xneu | 9 | 20% Inhibition at 10-6 M |
| 4179 | 14991605 | KIFGSLAFL | p369-CTL-A2xFVB | 9 | 8% Inhibition at 10-10 M |
| 4180 | 14991605 | KIFGSLAFL | p369-CTL-A2xFVB | 9 | 25% Inhibition at 10-9 M |
| 4181 | 14991605 | KIFGSLAFL | p369-CTL-A2xFVB | 9 | 80% Inhibition at 10-8 M |
| 4182 | 14991605 | KIFGSLAFL | p369-CTL-A2xFVB | 9 | 85% Inhibition at 10-7 M |
| 4183 | 14991605 | KIFGSLAFL | p369-CTL-A2xFVB | 9 | 92% Inhibition at 10-6 M |
| 4184 | 15313924 | HHPHG | HHPHG | 5 | IC50=92 µM |
| 4185 | 15313924 | HHPHGHHPHG | (HHPHG)2 | 10 | IC50=11.6 µM |
| 4186 | 15313924 | HHPHGHHPHG | (HHPHG)2 | 10 | IC50=26.9 µM |
| 4191 | 15467750 | GRKKRRQRRR | HIV-TAT48-57 | 10 | 7% apoptosis at 10 µM |
| 4192 | 15467750 | GRKKRRQRRR | HIV-TAT48-57 | 10 | 15% apoptosis at 20 µM |
| 4193 | 15467750 | GRKKRRQRRR | HIV-TAT48-57 | 10 | 35% apoptosis at 30 µM |
| 4194 | 15467750 | GRKKRRQRRR | HIV-TAT48-57 | 10 | 65% apoptosis at 50 µM |
| 4365 | 21882228, 18957441 | AWKLFDDGV | Cr-ACP1 | 9 | Not Available |
| 4429 | 15253156, 18957441 | ACSAG | EP5-1 | 5 | Not Available |
| 4450 | 15949629, 18957441 | KTCENLADTY | Sesquin | 10 | Not Available |
| 4469 | 22076954 | IELLQARGGC-Pem | Peptide-1 | 10 | IC50 = 2.17 µM |
| 4470 | 22076954 | IELLQARGGC-Pem-GGRRRRRRRR | Peptide-2 | 10 | IC50 = 2.64 µM |
| 4472 | 22076954 | IELLQARGGC-Pem | Peptide-1 | 10 | IC50 = 4.63 mM |
| 4576 | 21928125 | LIAHNQVRQV | p85 | 10 | Not Available |
| 4611 | 20802991 | CSSRTMHHC | Peptide-20 | 9 | at 100 µM 90% viablity |
| 4612 | 20802991 | CSSRTMHHC | Peptide-20 | 9 | at 100 µM 55% viablity |
| 4613 | 20802991 | CSSRTMHHC | Peptide-20 | 9 | at 100 µM 50% viablity |
| 4614 | 20802991 | CSSRTMHHC | Peptide-20 | 9 | at 100 µM 50% viablity |
| 4615 | 20802991 | CSSRTMHHC | Peptide-20 | 9 | at 100 µM 30% viablity |
| 4616 | 20802991 | CSSRTMHHC | Peptide-20 | 9 | at 100 µM 55-60% viablity |
| 4617 | 20802991 | CSSRTMHHC | Peptide-20 | 9 | at 100 µM 35-40% viablity |
| 4618 | 20964334 | KWKWKW | Dex-(KW)3 | 6 | at 10 µM 60% viablity |
| 4619 | 20964334 | KWKWKW | Dex-(KW)3 | 6 | at 10 µM 35-40% viablity |
| 5012 | 24676901 | KKWWKKW-Dip-K | LTX-315 | 9 | IC50=13.3 µM |
| 5013 | 24676901 | KKWWKKW-Dip-K | LTX-315 | 9 | IC50=12.7 µM |
| 5014 | 24676901 | KKWWKKW-Dip-K | LTX-315 | 9 | IC50=15.3 µM |
| 5015 | 24676901 | KAQ-Dip-QKQAW | LTX-328 | 8 | IC50= >350 µM |